UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053055
Receipt number R000059702
Scientific Title Frequency of adverse event of endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilatation (EPBD) for naive papilla in hemodialysis patients with common bile duct stones (A multicenter prospective study)
Date of disclosure of the study information 2023/12/11
Last modified on 2023/12/11 12:48:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Frequency of adverse event of endoscopic sphincterotomy or endoscopic papillary balloon dilatation for naive papilla in hemodialysis patients with common bile duct stones (A multicenter prospective study)

Acronym

A multicenter prospective study of adverse event rate of EST/EPBD in hemodialysis patients with common bile duct stones

Scientific Title

Frequency of adverse event of endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilatation (EPBD) for naive papilla in hemodialysis patients with common bile duct stones (A multicenter prospective study)

Scientific Title:Acronym

A multicenter prospective study of adverse event rate of EST/EPBD in hemodialysis patients with common bile duct stones

Region

Japan


Condition

Condition

Maintenance hemodialysis patients with naive papilla and with common bile duct stones

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Prospective assessment of adverse event rates of endoscopic sphincterotomy (EST) or endoscopic papillary balloon dilatation (EPBD) in patients with untreated papilla, common bile duct stones and maintenance hemodialysis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The frequency and severity of bleeding and pancreatitis post procedure in whole hemodialysis patients with common bile duct stones

Key secondary outcomes

1.The frequency and severity of bleeding and pancreatitis post procedure in hemodialysis patients with common bile duct stones performing EST or with EPBD, respectively
2.The frequency and severity of ERCP-related adverse events other than bleeding and pancreatitis post procedure in whole hemodialysis patients with common bile duct stones
3.The factors associated with bleeding in maintenance hemodialysis patients
4. The factors associated with pancreatitis post procedure in maintenance hemodialysis patients


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with untreated papilla (patients without previous EST or EPBD)
Patients over 18 years-old at the time of entry
Patients who have provided written consent for participation

Key exclusion criteria

Patients who have undergone EST or EPBD.
Patients who cannot switch to Nafamostat as the anticoagulant for hemodialysis fluid.
Patients judged by study investigator/subinvestigators as inappropriate ones

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tetsuo
Middle name
Last name Takehara

Organization

Osaka University Graduate School of medicine

Division name

Gastroenterology and Hepatology

Zip code

5650871

Address

Yamada-oka 2-2, Suita, Osaka, Japan

TEL

0668793621

Email

takehara@gh.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Minoru
Middle name
Last name Shigekawa

Organization

Osaka University Graduate School of medicine

Division name

Gastroenterology and Hepatology

Zip code

5650871

Address

Yamada-oka 2-2, Suita, Osaka, Japan

TEL

0668793621

Homepage URL


Email

m-shigekawa@gh.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Graduate School of medicine, department od Gastroenterology and Hepatology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Hospital Institutional Review Board

Address

Yamadaoka 2-2, Suita, Osaka, Japan

Tel

06-6210-8289

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 07 Month 24 Day

Date of IRB

2023 Year 08 Month 31 Day

Anticipated trial start date

2024 Year 01 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multicenter, prospective observational study


Management information

Registered date

2023 Year 12 Month 11 Day

Last modified on

2023 Year 12 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059702


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name